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ABSTRACT 
 
Mycotoxins can compromise immune function and lead to decreased animal health and 
productivity. In addition, aflatoxin (AF) can be transferred from the mammary gland to milk as 
AFM1, a carcinogenic metabolite of AF, thus generating a human food safety concern. Since 
mycotoxins are ubiquitous in various animal feedstuffs, dietary interventions to prevent their 
absorption are pertinent. Therefore, we postulated that supplementing a dietary adsorbent would 
help limit AFM1 in urine and milk. Consequently, objectives were to determine the effects of 
supplementing a silicoglycidol clay on milk and urine AFM1 concentration, transfer %, and 
excretion values and to determine the response of inflammatory biomarkers on an AF challenge. 
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CHAPTER 1: LITERATURE REVIEW 
 
Introduction 
Molds can infect many crops from cereal grains such as corn and cottonseed for livestock 
to nuts and fruits for human consumption (Jard et al., 2011; Marin et al., 2013). Under certain 
circumstances such as inadequate environmental conditions and insect damage, these molds can 
produce mycotoxins, which are secondary metabolites that have been identified to cause toxicity 
in humans and animals when there is occurrence in food and feedstuffs. The Food and 
Agriculture Organization of the United Nations (FAO) has estimated that nearly 25% of cereal 
grains produced globally are contaminated by mycotoxins, with an estimated annual cost to the 
U.S. agricultural industry averaging $1.4 billion (Rice and Ross, 1994; CAST, 2003; Bekele, 
2016). Plants can be contaminated with mycotoxins in different segments of the food supply 
chain such as pre-harvest (in the field), harvest and drying, or post-harvest (inadequate storage 
conditions, improper handling, and poor transport conditions).  Since many fungal species can 
thrive on crops throughout the different stages of the production cycle, mycotoxin production is 
likely to occur at some point. Since these metabolites are extremely small and stable molecules, 
they are ubiquitous in the global crop supply. 
The primary fungal genera that produce mycotoxins are comprised of Aspergillus, 
Pencillium, and Fusarium. From the 400 identified diverse secondary metabolites that are known 
to produce toxic effects, the five most common mycotoxins in agricultural commodities include: 
ochratoxin A, zearalenone, trichothecenes (type A: HT-2 and T-2 toxin; type B: deoxynivalenol), 
fumonisin, and aflatoxin (Jard et al., 2011; Marin et al., 2013; Tola and Kebede, 2016). Upon 
ingestion, inhalation, and skin contact, mycotoxicosis can occur in vertebrate animals (Bennett 
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and Klich, 2003; Marin et al., 2013; Tola and Kebede, 2016). Consumption of the contaminated 
diets have been noted to have acute and long-term chronic effects in animals and humans, 
including immunosuppression, carcinogenicity, and oestrogenicity (Fink-Gremmels and 
Malekinejad, 2007; Morgavia and Riley, 2007; Pestka, 2007, Voss et al., 2007). The reported 
effects of mycotoxicosis on livestock are reduced feed intake, decreased milk production, 
reduced body weight, and increased incidence of disease (Zain, 2011; Jard et al., 2011).	 
Mycotoxins constitute public health safety concerns and substantial economic losses. 
Firstly, pre-harvest contamination of feedstuffs is rapidly increasing due to problematic climate 
change and stressful growing conditions for multiple crops. Secondly, poor agricultural, 
harvesting and storage techniques exacerbate the likelihood of mycotoxin contamination. Lastly, 
regional and global trade involves transportation of crops that are, or will become, contaminated 
with mycotoxins, thus increasing the risk of exposure by animals and people. In the U.S.A. 
alone, the USDA, Cooperative State Research Education and Extension Service (CSREES), and 
Food and Drug Administration (FDA) spend approximately $31.1 million in mitigation strategies 
for mycotoxins annually (Kurtzman et al., 1987; Robens and Cardwell, 2003, FAO, 2004). 
Numerous countries worldwide have begun to adopt regulations to help decrease exposure. Feed 
manufacturing techniques, such as thermal treatment and irradiation, are not reliant to help 
decrease concentrations or completely eradicate the toxicity from feed sources. Thus, it is 
important to implement and explore strategies to help mitigate mycotoxin challenges. Focusing 
specifically on adsorbents, the use of sequestering agents seems to be a promising solution in 
order to combat mycotoxin challenges. 
  
3 
 
Primary Mycotoxins 
Ochratoxin A 
Ochratoxin A (OTA), a pentaketide that consists of dihydroisocoumarin coupled to β-
phenylaline, is a chemically stable compound. Produced from a variety of fungi including 
Aspergillus ochraceus, A. carbonarius, A. niger, and Pencillium verrucosum, which occur 
naturally in the environment (Pholand et al., 1992). These fungi can grow in a variety of regions, 
climates, and water activity, with the formation of OTA occurring primarily during storage due 
to high moisture content (>14%) and inadequate drying techniques (Denli and Perez et al., 2010). 
This metabolite can be classified as a 2b carcinogen by the International Agency for Research on 
Cancer (IARC) due to its toxic nature of acute and chronic effects. Sources of feedstuffs where 
OTA is produced are cereal grains, wine, coffee, chocolate, and preserved fruit (Bui-Klimke and 
Wu, 2015).  
Oral ingestion is the primary route of administration or exposure to OTA toxicity, with 
the kidney being the main organ of attack. Mycotoxicosis by OTA often causes renal 
carcinogenicity and nephrotoxicity (Bui-Klimke and Wu, 2015). The mechanism of action is still 
unknown, but it is postulated that OTA absorbed in the gastrointestinal tract, inhibits 
macromolecular synthesis and mitochondrial respiration, and increases lipid peroxidation 
(Kuiper-Goodman and Scott, 1989; Kőszegi, T. and M. Poór, 2016). In humans, OTA has been 
in question for global human health hazards including chronic interstitial nephropathy (CIN) and 
Balkan Endemic Nephropathy (BEN; Abouzied et al., 2002; Peraica et al., 2008; Denli and 
Perez, 2010).  
There has been a substantial health impact in livestock species with negative 
repercussions on animal productivity due to OTA-contaminated feed. It is noteworthy that 
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nephrotoxicity has been confirmed across all mammalian species (Hope and Hope, 2012). 
Impaired immune performance has been reported in multiple studies with poultry challenged 
with OTA doses ranging from 1 to 5 mg/kg of dietary concentration. Common results include 
decreased concentrations of circulating cholesterol, total protein, albumin, globulin, potassium, 
and triglycerides. Other biomarkers of metabolic or organ dysfunction have been noted as well 
during OTA toxicity. This included increased levels of uric acid, creatine, and serum alkaline 
phosphatase (ALP). Gamma glutamyl transpeptidase (GGT), a biomarker of liver damage was 
increased in poultry (Huff et al., 1988; Bailey et al., 1989; Gentles et al., 1999; Denli et al., 2008; 
Denli and Perez, 2010). Due to compromised health status as a result of chronic or acute 
exposure to OTA, the swine and poultry industries suffer economic losses as associated to 
reduced growth and decreased average daily gain, hence hampering animal performance (Huff et 
al., 1988; Malagutti et al., 2005). Even though, Malagutti et al. (2005) did not report any 
difference in body weight and feed intake in pigs exposed to OTA, average daily gain and feed 
efficiency were decreased compared the control pigs that were not exposed to the mycotoxin. 
Similarly, Huff et al. (1988) reported decreased body weight, feed conversion ratio and mortality 
when mimicking ochratoxicosis in broilers. Ruminant animals are noted to be more resistant than 
non-ruminants due to microbial biotransformation of some toxins in the rumen. Excretion of 
OTA has also been noted in lactating animals; Ribelin et al. (1978) injected a single dose of OTA 
at 13.3 mg/kg of body weight, verifying total excretion in milk of 4.5 mg of OTA (Battacone et 
al., 2010).  
Relatively few nations around the world implement maximum regulatory limits in food 
and currently in the United States, there are no action levels and regulations for OTA set by the 
F.D.A., such as in Brazil. Imported foods in the European Union (EU) have an allowable 
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maximum of 5 µg/kg in raw cereal grains, 3 µg/kg in processed cereal foods, and 10 µg/kg in 
dried vine fruits. Of particular concern are the limits for OTA in coffee, as it is one of the 
world’s most valuable and widespread cash crops; the limit in the EU is set at 5 µg/kg. It is 
difficult to implement a set maximum limit as the occurrence in different commodities is 
frequent and complete elimination is an unattainable objective (Mitchell et al., 2017). Due to the 
unknown parameters of public health and economic impacts, risk assessments are relatively 
difficult to conduct. In future directions, management and risk assessment protocols will be 
needed to help identify and prevent OTA-contaminated feed, as well as the use of binding agents 
to help block the adsorption of OTA in the gastrointestinal tract.  
Zearalenone 
Zearalenone (ZEA), a macrocylic B-resorcylic acid lactone, is an oestrogen mycotoxin 
produced by Fusarium fungi including F. graminearum, F. culmorum, F. cerealis, F. equiseti, F. 
crookwellense, and F. semitectum. These fungi are located in all continents and are invasive to 
cereal plants, particularly to corn, wheat, rice, and barley, often leading to contaminated human 
and livestock feed (Zinedine et al., 2007; Hueza et al., 2014). Even though ZEA may accumulate 
in the field with moist and cool conditions, many times ZEA is formed under improper storage of 
grains including high moisture content and inadequate drying techniques (Kuiper-Goodman et 
al., 1987). Comparable to other mycotoxins, ZEA is stalwart in high a thermal zone and 
extrusion of grain products making it difficult to remove or decompose during food or feed 
processing (Kuiper-Goodman et al., 1987; Bullerman and Bianchini, 2007; Hueza et al., 2014).  
Zearalenone in contaminated feedstuffs is quite hazardous due to the strong estrogenic 
activity, as it can be rapidly absorbed, metabolized, and bio transformed to active, and potent, 
metabolites after 30 minutes of oral exposure (Minervini and Aquila, 2008). Soy and clover 
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isoflavones are naturally occurring non-steroidal estrogens that have strong hormonal effects on 
livestock; the estrogenic effects of ZEA surpass that of soy and clover isoflavones (Bennett and 
Klich, 2003). Patterson (1978) hypothesized that ZEA goes through a folding such that hydroxyl 
groups are orientated to bind to tissue receptors, which would normally bind estrogen (Diekman 
and Green, 1992). The metabolites formed via biotransformation, α- and β-zearalenol (α- and β-
zol), have a strong binding affinity to the estrogen receptors, causing reproductive and 
developmental toxicity (Hueza et al., 2014). The primary organ responsible for the metabolism 
of steroids is the liver, but the kidneys, testes, prostate, hypothalamus, ovary, and intestine are 
affected by the negative effects of ZEA (Minervini and Aquila, 2008).  
 Across gravid female livestock species, ZEA has been reported to reduce embryonic 
survival and decrease fetal weight. Other alterations at different stages of production or growth 
include increased uterine size and decreased milk production (D’Mello et al., 1999; Zinedine et 
al., 2007). Gilts are notably the most sensitive to the estrogenic effects of ZEA. A single oral 
dose at 10.0 mg/kg BW was estimated at 80 - 85% uptake in pigs explaining the increased 
sensitivity (Zinedine et al., 2007). In a study conducted by Malekinejad et al. (2006), pigs 
converted ZEA into α-ZOL by hepatic biotransformation. When Obremski et al. (2003) fed pigs 
the concentration of 0.2 and 0.4 mg ZEA kg/BW/day during a 35-day period, results indicated 
ovarian follicle atresia and intensified proliferation in the uterus and oviducts. However, when 
0.35 mg ZEA kg/BW/day was fed to gilts, there were no differences between treatments on 
uterus weight (Doll et al., 2003). In male pigs, ZEA was noted to decrease weight of testes and 
spermatogenesis, depress testosterone, and suppress libido (D’Mello et al., 1999; Zinedine et al., 
2007). In ruminants, Seeling et al. (2005) investigated ZEA in Holstein cows with Fusarium 
contaminated wheat at 0.051 mg/kg dry matter intake (DMI). Results indicated steady recoveries 
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of α- and β-zol in feces at different levels of ZEA concentration in feedstuffs, suggesting that the 
rumen microflora help degrade the toxic substances (Fink-Gremmels and Malekinejad, 2007; 
Gromadzka et al., 2008). The concentration of ZEA and its metabolites were undetectable in 
milk, which seemingly represents no real concerns of food safety and dairy products.   
Risk assessments of ZEA have been conveyed using exposure and hazard evaluations, 
and even though the compound is found to be inherently toxic, the danger is only apparent when 
absorbed over a long exposure period with high concentrations. Sixteen countries in the 
continents of Europe, Asia, Africa, and South America have reported to have a maximum 
feeding level of ZEA as of 2003; however, the U.S. only has guidance (Zinedine et al., 2007; 
FAO, 2004). Again, it is strenuous to place advisory levels due to the inadequate testing 
procedures, not enough data across species, and being dependent on feed sources and 
concentration.  
Trichothecenes 
 Trichothecenes are secondary fungal metabolites, sesquiterpene epioxides, which are 
detrimental to humans and livestock. There are over 150 trichothecenes derivatives isolated and 
characterized (Gutleb et al., 2002; Rocha et al., 2005). The toxins produced by the most common 
species of the fungal genera Fusarium can be categorized as type A (T-2 toxin) and type B 
(deoxynivalenol: DON and nivalenol: NIV). These two categories are distinguished due to the 
presence of oxygen/carbonyl on the C-8 position, with type A having oxygen and type B toxins 
have a carbonyl group (Rocha et al., 2005). Compared to other fungal species, Trichotehcium 
species are often found prior to harvest in the soil instead of being produced by improper storage 
conditions; these fungi are responsible for wilts, blights, and ear rots in cereal grains 
(McCormick et al., 2011). Previous investigations have shown that the mechanism of action of 
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trichothecenes toxicity works via inhibition of mitochondrial protein synthesis in eukaryotes, 
inhibiting DNA and RNA synthesis, interacting with sulfhydryl groups, producing free radicals 
causing oxidative stress and inducing apoptosis (Cole et al., 1981; Rocha et al., 2005; 
McCormick et al., 2011). Due to the rapid absorption via the gastrointestinal tract, these toxins 
can quickly cause immunosuppression, decreased feed intake, hemorrhage, and vomit (Ueno 
1985; Fink-Grernmels 1999; McCormick et al., 2011).  
The toxic effects of T-2 toxin on livestock are quite complex and are generally more 
potent compared to DON (SCF 2002; Rocha et al., 2005). In vivo results indicate that the 
immune system is the most sensitive to T-2 toxin, including decreased concentrations of 
lymphocytes and fibroblasts (Holladay et al., 1993; Rocha et al., 2005). Due to 
theseimmunosuppressive effects, T-2 toxin increases susceptibility to secondary infections in 
livestock such as Mycobacterium bovis and Staphylococcus aureus. This toxin is also associated 
to reduce ovarian function and has the ability to decrease body weight (SCF 2002; Rocha et al., 
2005). Wyatt et al. (1973) reported decreased growth rate in broiler chickens with increasing 
doses of T-2 toxin. The highest treatment group was fed 16 µg/g of feed intake of T-2 toxin and 
was 60% of the spleen size relative to the control group. Weaver and researchers (1978) reported 
similar results with reduced body weight gain in pigs.  
The phytopathogenic Fusarium species that include F. graminearum and culmorum 
produce type B trichothecenes. There are two chemo-types that are classified as DON or NIV 
(Chandler et al., 2003; Rocha et al., 2005). Type B trichothecenes are generally more common in 
feedstuffs than T-2 such as oats, barley, wheat, and corn, and it is classified as a group 3 
carcinogen by IARC (McCormick et al., 2011). Deoxynivalenol has strong emetic effects after 
ingestion, often accompanied by diarrhea and gastroenteritis (Petska 2007; Sobrova et al., 2010). 
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Induced vomiting is thought to be produced by serotonergic activity in the central nervous 
system or peripheral action on the serotonin receptors (SCF 1999; Rosha et al., 2005). Chronic 
effects include decreased weight gain and anorexia. Swine are the most sensitive to DON, with 
poultry and ruminants being less sensitive due to low degrees of absorption in plasma and 
tissues, and rapid clearance (Petska 2007). In comparison, 1-2 mg/kg will cause toxicity in pigs, 
whereas ruminants and poultry can tolerate up to 20 mg/kg due to decreased amounts of 
bioaccumulation (Bergsjø et al., 1992; Pestka 2007).  
According to the FDA, guidance levels are recommended at 10 mg/kg in beef feedlot 
cattle and poultry. The level is decreased to 5 mg/kg in swine due to the emetic effects (FDA, 
2000). However, little research has been done to determine the economic impact as well as 
developing advisory levels for trichothecenes, even though these molecules globally cause many 
problems. In order to increase food and feed safety, more research will need to be conducted to 
establish maximum limits for these toxins.  
Fumonisins 
Some of the most prevalent fungi in cereal grains are Fusarium verticillodies (formerly 
known as moniliforme) and F. proliferatum, which are responsible for production of the 
mycotoxin, fumonisin (Voss et al., 2007). From the four types of fumonisins that have been 
characterized, FB1 and FB2 have the most harmful effects to mammalian species, whereas FB3 
and FB4 naturally occur in extremely low concentrations. F. moniliforme has been documented 
since the early 1900’s with the descriptions of livestock sloughing hooves, poultry shedding 
feathers, and animal deaths due to convulsions brought on by the consumption of moldy corn 
(Peters 1904; Nelson et al., 1993). Fumonisins have significant relevance in human health, these 
toxins have been linked to esophageal cancer, due to the incidence in Transkei region in southern 
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Africa, and neural tube defects in Texas, in addition to cardiovascular problems after 
consumption of contaminated corn (Marasas 2001; Missmer et al., 2006; Voss et al., 2007; 
Antonissen et al., 2014).  
Fumonisins are known to be cytotoxic, hepatotoxic, and nephrotoxic (Nelson et al., 1993; 
Gallo et al., 2015). It is hypothesized that the mode of action of fumonisin toxicity is via 
inhibition or alteration of sphingolipid metabolism, inducing apoptosis and oncotic necrosis. 
Other studies also indicated that fumonisins change key enzymes in cell cycle regulation such as 
inhibition of serine/threonine phosphatases, altered calcium homeostasis, and increased lipid 
peroxidation (Sauviat et al., 1991; Fukuda et al., 1996; Gelderblom et al., 1997; Riley et al., 
2001). Fumonisin B1 (FB1) produces a neurotoxic condition in horses, leukoencephalomalacia 
(LEM) and porcine pulmonary edema in swine (PPE) (Kellerman et al., 1990; Harrison et al., 
1990; Thiel et al., 1992). A variety of studies have reported PPE in the swine industry when 
feeding FB1 contaminated feedstuffs (Casteel et al., 1994; Fazekas et al., 1998; Haschek et al., 
2001). Compared to other mycotoxins, fumonisins are poorly degraded in the rumen, which 
makes ruminant animals susceptible to toxicity; clinical signs can include anorexia, diarrhea, and 
hepatic damage (Fink-Gremmels 2008; Gallo et al., 2015). In addition, adverse effects on the 
immune system have been reported, this condition increases susceptibility and severity of other 
diseases.  
A worldwide survey of mycotoxin contamination in a variety of feed samples revealed 
that 58% of samples were contaminated with fumonisins (Rodrigues 2008). Since fumonisin is 
the most frequent contaminant of grain, distiller’s grain, and finished feed, the need for dietary 
guidelines is warranted. The dietary guidelines are 4 mg/kg in feed ingredients intended for 
human consumption. Among farm animals, horses are the most sensitive to fumonisin toxicity, 
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thus the guidance for maximum tolerable level is 5 mg/kg, increasing to 20 mg/kg in swine, 30 
mg/kg in ruminants, and 100 mg/kg for broiler chickens (FDA, 2000). It has been estimated that 
the annual corn market loss is an average of $39 million, with animal health loss at $270,000 
million. The total loss due to fumonisin is estimated at $40 million US dollars (Wu, 2006; 
Bekele, 2016). Awareness of negative effects on animal and human health due to fumonisin 
exposure, along with feed monitoring and risk awareness is important to help minimize health 
hazards in livestock and humans.  
Aflatoxin 
Introduction 
Aflatoxins (AF), one of the more harmful mycotoxins, are of most concern due to its 
carcinogenic effects. They are primarily produced by the fungi Aspergillus flavus and A. 
parasiticus via the polykeptide pathway and it is estimated that 25% of global cereal grains, 
primarily corn, are affected by them (Kurtzman et al., 1987; FAO, 2004; Battacone et al., 2012; 
Pate et al., 2018). The average annual market loss in the U.S. due to AF in corn alone has been 
estimated to be $163 million in, with $132 million being through feed and livestock loss and $31 
million being through rejected food for human consumption (Wu, 2006; Bekele, 2016). 
Aflatoxins can be found worldwide but are most commonly produced in warm, subtropical and 
tropical climates (Mostrom and Jacobsen, 2011). Contamination can also occur in cottonseed, 
peanuts, tobacco, and oilseeds (Bennett and Klich, 2003). Selim Hamid et al. (2013) reported 
that 4.5 billion people are at risk for exposure of AF-contaminated feedstuffs worldwide. 
Consumption AF-contaminated feed or food can result in an acute effect causing reduced milk 
yield, feed intake, hepatic damage, and decreased production performance in livestock species. 
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Chronic exposure to AF will cause immunosuppression, impairment of hepatic function, poor 
reproduction, and stunted growth (Fink-Gremmels, 2007; Tola and Kebede, 2016). 
There are four primary strains of AF classified as B1, B2, G1, and G2. Aflatoxin B1 
(AFB1) is noted to be the most potent, and when fed to lactating animals, it is bio-transformed 
into a secondary metabolite, aflatoxin M1 (AFM1), in the liver. Due to the transfer of AF in feed 
to milk, human health safety is of great concern (Prandini et al., 2009). The International Agency 
for Research has classified AF as a group 1a carcinogen, with group 1 being the highest ranking 
of carcinogens (Peers et al., 1987; IARC, 2002). In the United States, the FDA has a set action 
threshold of 20 µg AFB1/kg of feed for in lactating dairy rations and 0.5 µg AFM1 /kg for in milk 
for human consumption. The threshold is much more stringent in the EU with limits of 5 µg 
AFB1/kg in feedstuffs and 0.05 µg AFM1 /kg of AFM1 in milk (Van Egmond 1995; FDA, 2000).  
Research studies have been conducted to determine the excretion, transfer rate, and 
concentration of AF in feed to milk in lactating animals. Additionally, studies have aimed at 
developing strategies to eliminate or detoxify AFM1 in milk. As noted with the other 
mycotoxins, AF are robust against extreme high temperatures, thus thermal treatment may be 
ineffective to remove AF during feed manufacturing and pasteurization techniques (268-269 C°; 
Kabak 2009; Peng at al., 2018). A more commonly applied method is the addition of adsorbents 
to feedstuffs to help inactivate or detoxify AF (Huwig et al., 2001; Whitlow, 2006). Dietary 
adsorbents work in the gastrointestinal tract by binding substances to their surface via charge 
distribution, accessible surface area and large pore sizes (Kabak et al., 2006).  
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Chemical Properties and Metabolism of AFB1 and AFM1 
Aflatoxins are a family classified as polysubstituted bis-difuranocoumarins and are noted 
to be strongly fluorescent when exposed to ultraviolet light; AFB1 and AFM1 are congruous in 
chemical properties being slightly soluble in water and insoluble in non-polar solvents with a low 
molecular weight (MdQuari et al., 2013; Marchese et al., 2018). They are metabolized by the 
hepatic microsomal cytochrome P450 1A2 (CYP450), allowing it to bind to DNA and other 
important cellular macromolecules (Coulombe 1993; Abrar et al., 2012).   
 
Figure 1. Chemical Structures of Aflatoxin B1 and Aflatoxin M1. Adapted from Marchese (2018) 
 
The mechanism of how AF elicits toxicity is still unknown, researchers believe that it 
begins with bio-activation of microsomal mixed function oxidase (MFO) enzymes, suggesting 
that it generates intracellular reactive oxygen species (ROS; superoxide anion, hydroxyl radical, 
and hydrogen peroxide) due to the formation of the reactive AFB1-8,9-epoxide (Coulombe, 
1993). This epoxide has a high binding affinity for DNA, forming AFB1-N7-Gua adduct, which 
promotes mutations in the nucleotide sequence. The formed reactive oxygen species will attack 
soluble cell compounds and membranes leading to impairment of cell function, inhibition of 
proteins, dysregulation of DNA and RNA synthesis, and cytolysis (Shen et al., 1995; Abrar et al., 
2012; Marchese et al., 2018). Once AF is absorbed in the small intestine, it binds to plasma 
albumin allowing transport throughout the body and can be excreted via urine by being 
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converted to AF dialdehyde (Wild and Turner, 2002; Abrar er al., 2012; Marchese et al., 2018).  
Aflatoxin B1 can be deactivated by reduced glutathione (GSH) that is conjugated to 
gluthathione-S-transferase (GST), conjugation with sulfates, and glucuronic acid. Due to the 
effectiveness of GSH and GST deactivation in variant species, resistant levels can be increased 
or decreased (Coulombe 1993). For example, it is thought that turkeys extremely sensitive to AF 
due to efficient activation of CYP450 and absence of GSH S-transferase in the liver (Klein et al., 
2002; Abrar et al., 2012).  
 
Figure 2. Metabolic Pathways of AFB1 and AFM1. Adapted from Neal (1998) 
 
Aflatoxin B1 is hydroxylated to the metabolite AFM1 in the liver, produced upon the 
activation of CYP450. Being slightly more polar and less toxic to AFB1, AFM1 is primarily 
considered a detoxification product. Wogan (1974) reports that it only shows 10% of the toxicity 
of its precursor (Marchese et al., 2018). However, AFB1 needs to be converted to its reactive 
epoxide to bind protein to produce toxic effects, whereas AFM1 can directly demonstrate toxic 
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potential with no activation of metabolic functions (Neal et al., 1998; Giovati et al., 2015). 
Studies have demonstrated that production of intracellular ROS are observed with AFM1. 
Therefore, the presence of this metabolite is concerning in dairy products such as milk, cheese, 
fresh cream, powdered milk, yogurt, and baby formula (Battacone et al., 2005; Giovati et al., 
2015; Zhang et al., 2015; Xiong et al., 2018).  
Aflatoxin M1 can elicit acute and chronic toxicosis, specifically hepatotoxicity, through 
the ingestion of contaminated dairy products (Giovati et al., 2015). Excretion of AFM1 in a 
steady state is established 24 h from initial AFB1 ingestion (Frobish et al., 1986; Sumantri et al., 
2012). However, initial appearance and excretion of the AFM1 metabolite in milk is detected in 
less than 10 hours after first ingestion and quantifiable levels occur in less than 15 minutes in 
plasma. The rapid response is possibly due the low molecular weight of AFM1 and passive 
mechanism of absorption through the gastrointestinal tract (Diaz et al., 2004; Masoero et al., 
2007; Sumantri et al., 2012). The collective effects of AF toxicity on rumen microbiota, toxin-
toxin interaction, immune system and changes in blood-milk barrier are key points of interest for 
future research. 
Toxicological Effects on Livestock Species  
Aflatoxin B1 produces an extensive range of toxicity across animal species and is 
classified as a hepatotoxin and hepatocarcinogen (JECFA, 1998; Rawal et al., 2010). 
Supplementary effects directly or indirectly associated with AFB1 are reduced growth rate, 
immunosuppression, decreased milk and egg production, anemia and reduced feed efficiency. 
Variation in susceptibility across animal species is apparent; poultry and dairy cattle can be 
affected by exposure to levels from 15 to 30 µg/kg per kg of BW, while mice have shown no 
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effects when consuming feed with as much as 150,000 µg/kg (Applebaum et al., 1982; Wogan, 
1992; Rawal et al., 2010). Young animals of all species are the most susceptible to aflatoxicosis, 
followed by pregnant and growing animals, with mature animals being the least susceptible. 
Action levels have been set in the United States for AF levels in feed according to the class of 
animal (Table 1).   
Table 1. Action levels of aflatoxin in grain regulated by the FDA in the United States 
Action Level (Parts per Billion; ppb) Class of Animal 
20 
Dairy 
Immature animals and poultry 
100 
Breeding cattle and swine 
Mature poultry 
200 Finishing swine 
300 Finishing cattle 
Adapted from FDA (2000) 
Poultry 
Aflatoxins were first discovered when 100,000 turkey poults consumed peanut meal 
contaminated with A. flavus resulting in hepatic necrosis, hyperplasia of bile ducts and sudden 
death (Newberne and Butler, 1969; Hussein and Brasel, 2001). The negative effects of AF on 
poultry performance have been recorded in many studies indicating responses of reduced body 
weight while having increased organ mass in liver and kidney, along with immunosuppression 
(Thaxton et al., 1974; Smith et al., 1992; Hussein and Brasel, 2001). Neldon-Ortiz and Qureshi 
(1992) reported a dose-dependent reduction in macrophage adherence potential from chickens 
exposed to 5, 10, and 20 µg/mL of AFB1, thus leading to cellular damage.  
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Swine 
 Hussein and Brasel (2001) reported that swine are one of the most sensitive species to 
AF, however, their immune response to AF challenges have been inconsistent. In a study 
conducted by Southern and Clawson (1979), AF was fed to 32 pigs randomly divided into four 
dietary treatments of 20, 385, 750, and 1,480 µg/kg total concentration of AFB1. For 
immunological parameters, total serum protein, albumin and IgG were not significant different 
among dietary treatments. However, IgM was increased in pigs receiving higher doses of AF at 
750 and 1,480 µg/kg AFB1. Other studies have also shown a similar response, where swine 
humoral immunity was not modified from AF levels of 0.4 – 500 µg/kg of feed (Miller et al., 
1981; Panangala et al., 1986). Even though humoral response may seem to have some degree of 
resiliency at higher levels of exposure, production performance has been reported to be 
depressed, namely 385 µg/kg of AFB1 resulted in reduced average daily gain and increased liver 
weight. The increase in liver weight may be a reflection of hepatotoxicity, this is supported by a 
report by Hussein and Brasel (2001) in which porcine liver from animals fed AFB1 was fed at 
1.48 mg/kg of feed had clear signs of hepatocellular lesions.  
Ruminants  
Ruminants are known to be less susceptible to the negative effects of AF compared with 
monogastrics, this is partly due to the ability of rumen microbes to partially degrade the some 
mycotoxins into a less toxic product. In the particular case of AF, it is noteworthy to highlight 
that absorption of this mycotoxin may occur even before entering the rumen via mucosal 
absorption; detectable levels of AFM1 in plasma have been reported as soon as 5 minutes after 
exposure to dietary contamination (Gallo et al., 2008, Mostrom and Jacobsen, 2011). Once 
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ingested, AF is only partially degraded by ruminal microflora (Fink-Gremmels 2008). Chronic 
aflatoxicosis in ruminants may lead decreased production performance such as reduced dry 
matter intake, lower milk production and consequently decreased feed efficiency, as well as poor 
reproduction. These effects on productive performance are likely related to an impairment of 
hepatic functions (Miller and Wilson, 1994) which lead to metabolic stress and lower 
productivity. 
In a review conducted by Richard et al. (1983), it was reported that steers consuming 800 
ng/g of AFB1 of naturally contaminated corn for 15 and 17.5 weeks had no clinical signs of 
toxicity and no adverse effects in weight gain and feed conversion were observed. However, 
AFM1 was detected in pooled blood and urine 14 days after removal of contaminated diets 
suggesting that there may be some adaptive metabolism to cope with prolonged exposure to AF. 
Similar results were reported for young crossbred steers fed AFB1 at levels < 300 µg/kg. On the 
other hand, when levels were fed 700 - 1000 µg/kg, results indicated lower weight gain, decrease 
feed efficiencies and enlarged/fibrous livers (Keyl and Booth, 1971; Mostrom and Jacobsen, 
2011).  
Aflatoxins have been studied extensively in dairy cattle due to the carry-over of AFB1 in 
feed to AFM1 in milk through absorption in the digestive tract (Applebaum et al., 1982; Prandini 
et al., 2009). Applebaum et al. (1982) reported that high-yield dairy cows are also more sensitive 
to AF than beef steers. Aflatoxin is absorbed via passive diffusion and it is then hydroxylated to 
the derivative AFM1 in the liver. This derivative can be conjugated to glucuronic acid, excreted 
via bile, or enter systemic circulation. Aflatoxin M1 can be excreted in urine, milk, and feces 
(Kuilman et al., 2000; Fink-Gremmels 2008). When dietary AFB1 levels were fed at levels of 20 
µg/kg of the diet, lactating dairy cows were reported to have decreased feed consumption and 
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milk production (Jones and Ewart, 1979). Matching effects of decreased milk production were 
reported with diets of AFB1 at 100 - 330 µg/kg of BW (Mertens and Wyatt, 1977; Guthrie and 
Bedell, 1979). However, Applebaum et al (1982) recorded a slight decrease in feed intake and 
milk yield due to an AF challenge, and the reported differences were not significant when fed 13 
mg of AFB1 from pure and impure Aspergillus parasiticus in culture.  
Immune functions, including blood parameters, have been able to detect toxic effects of 
AF. Mertens and Wyatt (1977) reported an elevation of cholesterol and bilirubin at 110 µg/kg of 
BW and additionally serum alkaline phosphatase, glutamic oxaloacetic transaminase, lactic 
dehydrogenase at 330 µg/kg of BW during an AF challenge. However, Applebaum (1982) and 
researchers hypothesized that detrimental acute toxicities in the liver may be the least of 
concerns; consumption of low levels of AF is a greater concern due to the transfer to milk. This 
makes the need for sequestering agents in feedstuffs necessary in times of AF challenges. 
Post-Harvest Mitigation 
Numerous studies have been conducted by the livestock and feed manufacturing industries to 
help ameliorate the toxic effects of AF post-harvest. Examples include cleaning and sorting of 
grains (Huff and Hagler, 1985; Kabak et al., 2006), irradiation (Karlvosky et al., 2016), thermal 
treatment (Peers and Linsell, 1975), biotransformation (Lillehoj et al., 1967) and cold plasma 
technology (Dasan et al., 2016). However, most of these AF mitigation techniques are expensive, 
only partially effective, laborious and a human and animal health and food safety concern. 
Ideally, animals should be fed mycotoxin-free feed, however, mycotoxins are ubiquitous and this 
approach is virtually impossible due to practical and economical implications. Therefore, the use 
of adsorbents in livestock diets has been one of the most effective and feasible solutions to 
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mitigate myotoxicity’s of these additives are generally recognized as safe (GRAS) and are 
relatively inexpensive, easy to handle and incorporation into diet is simple at feed mills and also 
on farm. 
Adsorbents 
Adsorbents, or binders, are a physical method to remove or decrease concentrations 
mycotoxins in feed by forming a strong bond between the mycotoxin and the adsorbent, thus 
rendering the toxin unavailable for absorption in the gastro-intestinal tract (Huwig et al., 2001; 
Kabak et al., 2006). According to Huwig et al. (2001), efficacy, specificity, and mechanism of 
adsorption are the three major categories of how binders function. There is a myriad of 
adsorbents that differ in physical and chemical traits such as pore size, surface area and charge 
distribution. Efficacy also depends on the adsorbate, mycotoxins, including the size, shape, 
polarity, and solubility (Kabak et al., 2006). The use of adsorbents is globally the most applied 
way to combat mycotoxins and understanding how they work is imperative to reduce 
mycotoxicosis in livestock. Activated carbons (AC), yeast derived products, algae based 
compounds, hydrated sodium calcium aluminosilicate (HSCAS), and bentonite will be discussed 
in further detail to outline the adsorption process in regard to aflatoxin. 
Activated Carbons (AC) 
Activated carbons (charcoal) are a family of carbonaceous substances with relatively high 
affinity for toxins. They are formed by pyrolysis of organic compounds, these type of adsorbents 
have very small particle size which results in a significant surface area (500-3500 m2/g), and are 
highly porous (Ramos et al., 1996; Galvano et al., 2001; Kabak et al., 2006). 
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 Previous studies have revealed that AC can bind to AF in vitro and in vivo across 
multiple livestock species including poultry, goats, and dairy cattle (Jindal et al., 1994; Galvano 
et al., 1996; Edrington et al., 1997; Rao and Chopra; 2001). Galvano and colleagues (1996) 
reported that various forms of AC have strong binding affinity in vitro; in their report, 17 forms 
of AC were tested for absorption ability and physiochemical parameters. Results indicated a 
range of 44.47 – 99.82% adsorption ability, with four of the AC having 99% and higher binding 
capacity. However, Diaz (2004) reported no effectiveness of AC binding in vitro.  Galvano and 
colleagues (1996) reported a strong affinity for AC in vivo. Twelve multiparous Friesian cows 
were fed two commercial AC adsorbents at 2.0% of the diet with an aflatoxin challenge at 12 
µg/kg AFB1; results reported a significant reduction in AFB1 concentration in milk from 28 
µg/kg to 2.68 µg/kg and 6.70 µg/kg, for the control and the 2 AC products, respectively. 
Reduction of carryover as proportion of the control treatment was 50% and 27% for the 2 
products. Similar results were reported by Rao and Chopra (2001) when nine lactating goats 
were supplemented with 1% of DMI as AC, resulting in a reduction of AFB1 concentration and 
excretion in milk equivalent to 55.8 and 58.1% relative to the control without affecting milk 
composition. Even though, AC has been shown to decrease excretion of AFM1 in milk, it had no 
protective effects against aflatoxicosis in growing broiler chicks (Edrington et al., 1997). The 
authors were not able to provide an explanation for the null effect of AC, but Huwig et al. (2001) 
mention that AC has low specificity and that it may bind essential nutrients whose concentration 
is greater than the concentration of mycotoxins in the feed. Therefore, AC may have limited or 
marginal benefits if they bind nutrients and toxins with no specific pathways. 
Even though past research has shown that AC is effective at mitigating mycotoxicity, 
Galvano et al. (2001) posed three potential questions or implications regarding the use of AC as 
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a dietary adsorbent. The first question is with regards to long-term implications of adsorption to 
essential organic nutrients such as vitamins and minerals; the second is concerning the black 
color of the adsorbent and potential to contaminate the feed and surrounding environment; and 
the third issue pertains to economic feasibility of including AC into animal diets.  
Yeast Derived 
Presently, there has been an increased interest in the use of biological agents, such as 
yeast and yeast cell walls, as potential mycotoxin adsorbents. In the early 1990’s, Saccharomyces 
cerevisiae strain 1026 was utilized as a performance promoter; responses showed that it 
increased weight gain and increased immune response in broilers during an AF challenge 
(Stanley et al., 1993; Devegowda et al., 1998; Galvano et al., 2001). Other specific organic 
polymers derived from yeast cell walls include cellulose, glucomannans, and peptidoglycans 
(Galvano et al., 2001). Yeast products are commonly included in animal diet as it may have a 
positive effect on ruminal VFA production, gut morphology, and reducing inflammatory 
responses (Xiao et al., 2016; Jiang et al., 2018).  
Dawson et al. (2001) evaluated binding of AFB1 to a yeast cell wall product using 
isotherm equations. Results indicated that it was effective at binding AFB1 at low concentrations, 
thus showing high affinity for AFB1 to yeast. In regard to studies conducted with utilizing 
Saccharomyces cerevisiae fermentation products (SCFP) for dairy cows, Poppy et al. (2012) 
conducted a meta-analysis summarizing 36 studies with 69 comparisons; results of the meta-
analysis describe a positive response in DMI, milk yield, milk fat, and milk protein yield. Due to 
the improved animal performance, it was postulated that SCFP might have a positive effect on 
the animal during an AF challenge. Diaz et al. (2004) reported yeast cell wall esterified 
glucomannans bound AFB1 in vivo at an inclusion of 0.05% of the diet, compared to the 
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bentonites that were fed at 1.25% of the diet. However, SCFP have also found to be ineffective at 
higher doses when fed at 0.56% of the diet (Kutz et al., 2009). Jiang et al. (2018) fed an AF 
challenge, a clay diet (CL), and a clay diet containing SCFP (CL + SCFP). Results were similar 
between CL and CL + SCFP when evaluating milk concentration, excretion, and transfer of 
AFM1, revealing that SCFP seemed to have no effect on AF mitigation. However, milk yield 
tended to increase compared to the toxin group where clay had no significant effect; this might 
be due to possible improved rumen fermentation and DM digestibility with the addition of SCFP. 
Milk protein yield was greater in cows that received the CL + SCFP diet due to the numerical 
increase in milk yield. While yeast derived products differ greatly in terms of composition and 
compounds in the product, these feed additives may offer an alternative to clay-based 
compounds that are usually added at high concentrations (> 1.0%) in the diet. Adsorbents with a 
high affinity and greater adsorptive capacity at lower concentrations in the diet (< 0.1%) are 
preferred because the effect on dietary nutrient density is minimized while maintaining binding 
specificity to toxins (Diaz and Smith, 2005).  
Algae Based  
Even though marine plants have been used for centuries for medicinal purposes, the use 
of algae as a dietary adsorbent is a recent and active area of interest. Today, marine plants are 
utilized in anticoagulants, antibiotics, anthelmintic, and dilatory agents (Mosaad et al., 2006). It 
is thought that the use of algae could have a chemoprevention action against AFB1 thus reducing 
the negative health effects of this toxin. Blue-green algae such as Spirulina platensis and 
Shewanella and red algae such as Laurencia obtusa and Caulerpa prolifera are rich in vitamins, 
minerals, essential amino acids, fatty acids, and carotenoids. The most important property from 
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an adsorbent standpoint is the possession of profound antioxidant properties and respiration with 
an array of electron acceptors.  
Gong and other researchers (2015) utilized the Shewanella algae strain YM8 to help 
screen for antifungal activity, specifically against AF. This type of algae produces volatile 
organic compounds (VOC) that could have antifungal properties. Even though 15 VOC were 
detected, only six VOC had a reference standard for identification. These six VOC significantly 
reduced mycelial growth and conidial germination of Aspergillus; it also completely inhibited 
AF biosynthesis in maize and peanut samples. Another study researched the effects of Laurencia 
obtusa and Caulerpa prolifera to mitigate toxicosis an AFB1 induced challenge in Sprague-
Dawley rats (Mosaad et al., 2006). The rats were fed an AFB1 contaminated diet of 3 mg/kg for 
six days, and then fed pure AF for an additional four days at 200 µg/kg BW with either two of 
the marine algae extracts. Co-treatment wit the two extracts improved feed intake, BW, serum 
leptin, glutathione peroxidase, and superoxide dismutase. When comparing both alga extracts, 
Caulerpa prolifera was more effective in protecting against AFB1-induced hepatotoxicity. In the 
future, more research will be needed to determine the in vivo effects of algae extracts and AF 
challenges across different livestock species.  
Hydrated Sodium Calcium Aluminosilicates 
The most extensively researched adsorbent is hydrated sodium calcium aluminosilicates 
(HSCAS), which is a type of montmorillonite belonging to the group phyllosilicates. A 1:1 or 
2:1 arrangement of aluminum and silicon are connected to form multiple layers. The mechanism 
of action works through the exchange of calcium ions and protons against sodium ions (Huwig et 
al., 2001); HSCAS has been found to have a high affinity for AF (Phillips et al., 1988; Kabak et 
al., 2007). Phillips et al. (1999) reported the mechanism of how AF adsorbs to HSCAS, 
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postulating that AF react with multiple sites on the clay particles with formation of a complex in 
the β-carbonyl system. Reaction sites include edges, basal surfaces and interlayer regions 
forming a chemisorption mechanism. The maximum quantity of AF that can be bound was 
thought to be 200-232 nmol/milligram and the reaction reaches equilibrium at 30 minutes post 
reaction (Grant and Phillips, 1998; Phillips, 1999; Huwig et al., 2001). Aluminosilicates have 
strong efficacy against AF, but their efficacy for other problematic mycotoxins are limited due to 
a narrow binding range (Ramos et al., 1996; Huwig et al., 2001; Lemke et al., 2001).  
In one of the first studies conducted by Phillips et al. (1988), HSCAS was utilized in vivo 
to help prevent aflatoxicosis in broiler chicks after conducting in vitro binding capacity trials. 
The sorbent had an inclusion of 0.5% in the diet, containing approximately 7.5 mg/kg AFB1; 
results indicated that growth inhibitory effects produced by AFB1were decreased, and hepatic 
abnormalities were reversed. Swine performance has been extensively researched to determine 
production parameters with the use of HSCAS. Beaver et al. (1990) utilized an inclusion of 0.5% 
of HSCAS with finishing swine, with an AFB1,2-contaminated diet of 500-600 ng/g. 
Concentration of residues of AFM1 were reported to decrease in vital organs, including liver and 
kidney, muscle, and adipose tissue.  
Congruent findings of decreased AFM1 concentrations in milk have been cited 
extensively throughout literature (Harvey et al., 1991; Stroud et al., 2006; Kutz et al., 2009; 
Xiong et al., 2015). Kutz and coworkers (2009) conducted an experiment with three commercial 
HSCAS adsorbents to determine reduction of AFM1 concentrations in milk utilizing dairy cattle. 
Dietary treatments contained 112 µg/kg of AFB1 of DM and inclusion of 0.56% of adsorbent. 
Results indicated that two of the adsorbents significantly reduced AFM1 concentrations in milk 
by 45% and 48% and excretion by 44% and 46%, respectively. Similarly, Stroud et al. (2006) 
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and Harvey et al. (1991) reported 44% and 43% reduction in AFM1 in milk, respectively. Xiong 
et al. (2015) reported that adding aluminosilicate clay to a diet that contained 0 or 20 µg of 
AFB1/kg decreased AFM1 concentration, improved antioxidant status, and altered rumen 
fermentation. When levels reached 40 µg of AFB1/kg, the adsorbent had no effect on AFM1 
output or antioxidant status.  
Bentonite 
Bentonites are phyllosilicates with a layered crystalline microstructure, with adsorption 
depending on interchangeable cations: NA+, K+, Ca++, and Mg++. It is primarily composed of 
montmorillonite and the ion that composes the greatest amount of the compound will give its 
classification. For example, there are multiple types of compounds including sodium bentonite, 
potassium bentonite, calcium bentonite, etc. (Ramos et al., 1996; Stroud et al., 2006; Galvano et 
al., 2011). Bentonite has been shown to have binding capabilities that can significantly reduce 
the bioavailability of AFB1 in vitro and in vivo across all livestock species including swine, 
broilers, and ruminants (Masimango et al., 1978; Lindemann, et al., 1993; Santurio, 1999; Rosa 
et al., 2001; Diaz et al., 2004; Miazzo et al., 2005).  
In 1978, Masimango et al. compared 19 different clays to determine the absorption 
capacity to AFB1 in vitro. The three bentonite samples adsorbed between 95-100% of 400 µg 
AFB1 in the buffer solution at pH of 6.5; Ramos et al. (1996) reported similar results indicating a 
high capacity of bentonite to sequester AF. The efficacy of bentonite has been evaluated in many 
poultry studies. Rosa and associates (2001) worked with broilers and compared four treatments, 
namely control, AF challenge, clay with no AF challenge, and the binder with AFB1 at 5 mg/kg 
of feed. The results showed no differences between BW gains of the broilers fed control diet and 
those fed with AF + bentonite, suggesting that bentonite ameliorated the effects of AF. However, 
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histopathological findings suggested that the clay did not protect the liver. Moderate hepatic 
steaotsis was recorded in the AF + bentonite and the AF challenge treatments. Santurio (1999) 
observed similar treatment effects with body weight of broilers improving at 42 d of age with 
addition of sodium bentonite to an AF challenge. Body weights were improved by 31.3% and 
feed intake by 23.8%. Yet, weights of liver, heart, pancreas, and crop were not affected by the 
addition of the sorbent. These two studies suggest that bentonite has a moderate protection 
against AFB1. Lindemann et al. (1993) fed sodium bentonite (0.5%) to finishing swine diets that 
contained a concentration of 800 µg/kg AFB1. The adsorbent improved average daily gains and 
feed intakes compared to the AF treatment. The bentonite supplementation improved blood urea 
concentrations, total protein, and albumin. Additionally, liver enzymes including aspartate 
aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT) 
were improved.  
Applebaum and Marth (1982) determined the elimination of AFM1 from naturally 
contaminated milk with the use of 0.1, 0.2, and 0.4 g of sodium bentonite / 20 mL of milk. The 
results indicated 65%, 73%, and 89% adsorption of AFM1, respectively. Diaz et al. (2004) 
explored the use of four bentonites, which all did significantly reduce AFM1 concentrations in 
milk. It was noted that calcium bentonite was not as effective as the other three sodium 
bentonites, possibly due greater swelling capacity with sodium with increased surface area 
(Huwig et al., 2001). It is important to highlight that some studies have shown conflicting data, 
for example, Sumantri and researchers (2012) reported that there were no significant differences 
in AFM1 concentration in milk, carry over rate, milk production, and milk composition when 
feeding bentonite at 0.25% and 2.00% of the concentrate feed. 
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Conclusion 
Since mycotoxins are almost unavoidable and ubiquitous, their occurrence is a pressing 
and threatening issue to the global food supply via direct contamination of food or through 
transfer from animal feed to animal products. The health effects of mycotoxins on livestock and 
humans are detrimental and span from immunosuppression to being known carcinogens and 
mutagens. The utilization of post-harvest applications such as adsorbents has been found to be 
promising to help sequester mycotoxins in the gastrointestinal tract of the animal, therefore 
reducing bioavailability. Due to its carcinogenic effects and translocation from blood to milk, AF 
mitigation has received a great deal of interest and adsorbents have been researched primarily to 
help mitigate AF challenges. Feed additives such as activated carbons, yeast + yeast cell wall 
extracts, hydrated sodium aluminosilicates, algae-derived substances, and bentonites show 
varying degrees of efficacy with some having more potential to help overcome aflatoxicosis in 
livestock species. With the increasing pattern of severe weather in multiple geographical 
locations, AF will remain as a predominant concern, especially to the dairy industry. The 
importance of research to determine ways to efficiently and accurately measure AF in feedstuffs, 
utilize feed additives that help prevent or decrease concentration of AF in feed and help reduce 
the transfer and excretion levels into milk is essential.  
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Abstract 
Aflatoxin M1 (AFM1) is a carcinogenic metabolite transferred from feed into milk, thus 
posing a risk in the human food supply chain. Therefore, effective mitigation strategies are 
needed to reduce animal and human exposure to aflatoxins. The study objectives were to 
evaluate a silicoglycidol clay (ATX) as a sequestering agent in dairy diets contaminated with 
aflatoxin (AF), and to examine liver function upon an AF challenge. To do so, 12 primiparous 
Holstein cows (279 ± 88 days in milk and 675 ± 19 kg body weight) were used in replicated 3 × 
3 Latin squares with 21-d periods in which d 1-14 were considered adaptation and data collected 
on d 15 to 21 were used for analysis. Treatments were: 1) Control (CON) consisting of a basal 
diet; 2) aflatoxin diet (AF) consisting of CON + AF challenge (100 µg of AFB1/kg dry matter 
[DM]); and 3) AF + silicoglycidol clay (AF+ATX) consisting of AF + clay at 0.10% of dietary 
DM. Feed intake and milk yield were recorded daily, blood samples were collected on d 21 of 
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each period, and milk samples were collected on the last 2 days of each period. Data were 
analyzed using the MIXED procedure of SAS with square, period within square, and treatment 
as fixed-effects and cow within square as a random-effect. Milk yield and DM intake were 
similar across treatments averaging 26.8 ± 1.3 kg/d and 24.0 ± 0.9 kg/d, respectively. Similarly, 
milk composition was unaffected by treatment, as well as DM digestibility (62.8 ± 2.7 %). No 
AFM1 was detected in CON cows for milk and urine. The addition of AF and AF+ATX had no 
effect on blood concentration of alanine aminotransferase (61.1 ± 3.5 IU/L), aspartate 
aminotransferase (72.6 ± 5.5 IU/L), γ-glutamyltransferase (77.4 ± 7.0 IU/L), immunoglobulin G 
(158.0 ± 7.1 mg/L), and haptoglobin (1.1 ± 0.4 µg/mL). Supplementation with silicoglycidol 
reduced transfer of AFM1 from 1.65 ± 0.1% with the AF diet to 1.19 ± 0.1% with AF+ATX 
resulting in lower concentration of AFM1 in milk (1.57 to 1.14 ± 0.1 µg/L for AF and AF+C, 
respectively). Consequently, excretion of AFM1 was reduced by 11.64 ± 4.36 µg/d with the 
addition of ATX. Concentration of AFM1 in urine was 9.9 ± 1.2 µg/L for the AF diet whereas the 
inclusion of ATX resulted in 41% less AFM1 in urine. Urinary excretion was 2.3-fold greater in 
the AF challenged cows compared to those consuming ATX. Total fluid transfer of AFM1 was 
decreased from 26 ± 5.6% in the AF group to 11.7 ± 6.0% for the AF+ATX group. Cows that 
consumed AF had numerically 25.2% lower concentration of circulating haptoglobin compared 
to the AF+ATX diet, however, lack of response on liver enzymes after prolonged exposure 
suggests that evaluating liver function earlier in the challenge phase may be a better approach. 
These results demonstrate that the inclusion of silicoglycidol clay reduces absorption, transfer, 
and excretion of dietary aflatoxin to milk and urine. 
Keywords: binder, mycotoxin mitigation, liver enzymes 
  
43 
 
Introduction 
The USDA’s Agricultural Research Service (ARS), Cooperative State Research 
Education and Extension Service (CSREES), and Food and Drug Administration (FDA) spend 
approximately $31.1 million in mitigation strategies for mycotoxins annually (Robens and 
Cardwell, 2003). Within mycotoxin, aflatoxins (AF) are of special concern; these mycotoxins are 
primarily produced by the fungi Aspergillus flavus and A. parasiticus, and it is estimated that 
25% of cereal grains, primarily corn, are affected by AF worldwide (Kurtzman et al., 1987; 
FAO, 2004). Consequently, approximately 4.5 billion people are at risk of exposure to aflatoxin-
contaminated foods (Selim Hamid et al., 2013). When AFB1, an AF derivative, is fed to lactating 
animals, it is bio-transformed into a secondary metabolite, AFM1, in the liver. This metabolite is 
either conjugated to glucuronic acid, excreted via bile, or enters systemic circulation. In the latter 
case, aflatoxin is excreted in urine and milk (Fink-Gremmels, 2007). Since aflatoxin and its 
derivatives are carcinogenic, mutagenic, and immunosuppressive, human health safety is of great 
concern, principally with AFM1 because it is a more potent toxin compared to its parent molecule 
(Prandini et al., 2009). The International Agency for Research has classified the AF as Group 1 
carcinogens; this category is used when there is significant evidence of carcinogenicity in 
humans (Peers et al., 1987; IARC, 2002). To ensure safe food supply in the United States, the 
FDA has a set an action threshold of 20 µg/kg for AFB1 in rations for lactating dairy cows and 
0.5 µg/L for AFM1 in milk (FDA, 2000).  
Consumption of aflatoxin-contaminated diets can have an acute effect causing hepatic 
injury, poor feed conversion, and reduced milk yield (Applebaum et al., 1982; Fink-Gremmels, 
2008). Chronic exposure to AF will cause immunosuppression, impaired hepatic function, poor 
reproduction, and stunted growth across many livestock species (Fink-Gremmels, 2007; Tola and 
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Kebede, 2016). The mechanism of AF toxicity has not been fully elucidated. Lunn et al. (1999) 
described that AFB1 mediates the carcinogenicity through the formation of AFB1-guanine 
adducts. The unstable adducts can form either stable ring-open structures or go through 
spontaneous depurination. Intracellular reactive oxygen species such as superoxide anions, 
hydroxyl radicals, and H2O2 may be generated when cytochrome P450 metabolizes AFB1 in the 
liver. It is thought that these species may damage cell-wall compounds and membranes, 
ultimately impairing cell function (Abrar et al., 2013). 
Aflatoxins can be produced pre- and post-grain harvest, and they are influenced by 
unfavorable environmental conditions such as drought and humidity, improper drying, and 
improper packaging and storage techniques (Marin et al., 2013). Considerable research has been 
conducted to develop methods than can mitigate mycotoxin challenges. Pre-harvest methods 
focus on selecting seed varieties that are resistant to Aspergillus spp. and withstand insect 
damage, as well as varieties adapted to specific growing areas (Payne and Widstrom, 1992). 
Crop rotation and application of insecticide and fungicides agents to harvested feed before 
ensiling also prevent fungal growth (Cotty and Jaime-Garcia, 2007; Sulzberger et al., 2017). 
Post-harvest management practices include maintaining moisture below 15% in storage, cleaning 
of facilities, and following proper guidelines for silage processing (Ogunade et al., 2018). 
Feed additives, like adsorbents, can be utilized for inactivation or detoxification (Huwig 
et al., 2001; Whitlow, 2006) of mycotoxins. There are a wide variety of adsorbents; differing in 
physical structure of the constituent molecules, electrical charge, charge distribution, accessible 
surface area, and pore size (Huwig et al., 2001; Kabak et al., 2006). Most studies have focused 
on aluminosilicates, (primarily hydrated sodium calcium aluminosilicates (HSCAS), zeolites, 
bentonites, and activated charcoal. Phillips et al. (1988) demonstrated that 80% of AFB1 can be 
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absorbed by HSCAS in vitro, but this efficacy may be dose dependent (Smith et al., 1994). 
Phillips et al. (1999) described a potential mechanism for HSCAS binding to aflatoxin using the 
formation of a β-carbonyl system of the aflatoxin with exchange of the aluminum ions. Hydrated 
sodium calcium aluminosilicates belong to the group phylosilicates, which contain layers of 
aluminum and silicon that are connected in a 2:1 or 1:1 ratio (Huwig et al., 2001). This type of 
adsorbent is used to sequester aflatoxin in the gastro-intestinal tract (Huwig et al., 2001). Even 
though these feed additives can reduce the concentration of AF in milk, this toxin is very stable 
and resilient. Furthermore, they are effective for aflatoxin adsorption, but they may have little 
affinity for other toxins such as ochratoxin A (OTA), zearalenone (ZEA), and deoxyivalenol 
(DON) (Huff et al., 1992; Patterson and Young, 1993; Abbès et al., 2007). Silicoglycidol has 
been shown to bind more than one mycotoxin at low doses in swine but, to our knowledge, there 
is no report of its efficacy in ruminants (Binder et al., 2017). Therefore, the objectives of this 
study were to determine the effects of silicoglycidol clay on production response, immunity and 
liver function during an AF challenge in dairy cows. We postulated that dietary supplementation 
with this clay would reduce AFB1 absorption, thus reducing AFM1 concentration in milk and 
urine with a concomitant mitigation of inflammatory responses.  
 Materials and Methods 
Animals, Experimental Design, and Treatments 
 All procedures were approved by the Institutional Animal Care and Use Committee of 
Iowa State University (Ames, IA). Twelve primiparous Holstein cows (279 ± 88 DIM and 675 ± 
19 kg BW; mean ± SD) were used in replicated 3 × 3 Latin squares. In each 21-d period, cows 
within a square were randomly assigned to 1 of 3 dietary treatments: 1) control (CON), 
consisting of a basal TMR; 2) aflatoxin (AF), consisting of the TMR plus AF challenge; and 3) 
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AF+ATX similar to AF but supplemented with 0.10% silicoglycidol (ATX), Alquerfeed 
Antitox, (Biovet S.A., Tarragona, Spain). In-vitro characterization of the clay binding ability is 
presented in Table 1. It was estimated that cows would consume 28 kg of DM of a diet 
formulated to meet or exceed the predicted requirements (NRC, 2001; Table 2). Therefore, ATX 
was mixed in with an allotted 2.5 kg of TMR at 0.10% of predicted DMI. Similarly, the AF 
challenge was carried out by feeding a daily dose of 100 µg/kg of estimated DMI via mixing in 
with the allotted 2.5 kg of TMR. Aflatoxin utilized in the trial was produced as described by 
Showell et al. (1966) and modified by West et al. (1973). In brief, the AF was produced though 
fermentation of rice by A. parasiticus NRRL-2999. The resulting rice powder media was 
obtained from the University of Missouri Veterinary Medical Diagnostic Laboratory, Columbia, 
MO and contained 100 mg/kg AFB1/13 kg. The contaminated powder was mixed with ground 
corn. The profile and the concentration of AF content in the blended powder meal was 103 mg 
AFB1/kg, 3 mg AFG1/kg, 35 mg AFB2/kg, and 1 mg AFG2/kg.  
Cows were housed in a free-stall barn equipped with individual feeding gates (Calan 
Broadbent Feeding System; American Calan, Northwood, NH). Daily care involved milking at 
0000, 0900, and 1600h, and all milk was discarded because of AF treatments. Cows were fed a 
TMR which was delivered once daily (0600 h), an initial aliquot of 2.5 kg was given to the cows 
with their respective treatment mixed in with the remainder feed being offered upon full 
consumption of the initial aliquot. Orts were recorded daily 1 h before feed delivery. 
Sampling and Data Collection 
Feed analyses. Samples of the basal TMR were collected on d 20 and 21 of each period 
and pooled to obtain a composite sample by period. Feed samples were placed in a forced-air 
oven at 65°C for 48 h to determine DM, subsequently ground (1-mm screen; Wiley Mill, Arthur 
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H. Thomas Co.; Philadelphia, PA) and stored at room temperature. The diet was analyzed for 
nutrient composition by an external laboratory (Cumberland Valley Analytical Services; 
Waynesboro, PA). Analyses included DM (method 930.15; AOAC International, 2000), starch 
(Hall, 2009), ether extract using diethyl ether as the solvent (method 2003.05; AOAC 
International, 2006), NDF (Van Soest et al., 1991), ADF (Van Soest et al., 1991) and ash 
(method 942.05; AOAC International, 2000). Determination of DM of corn silage was 
performed once weekly to adjust the TMR accordingly. 
Fecal and urine analyses. Indigestible neutral detergent fiber (iNDF) was used as an 
internal marker to estimate fecal output to determine apparent total tract digestibility based on 
fecal samples collected on d 20 of each period. Fecal samples were dried and ground as 
previously described for feed samples. Dry and ground fecal samples from each cow were 
analyzed for DM (method 930.15; AOAC International, 2000), ash (method 942.05; AOAC 
International, 2000), NDF (Van Soest et al., 1991), and ADF (Van Soest et al., 1991). 
Determination of iNDF was performed in quadruplicate by incubating 5 × 10 cm Dacron bags 
containing 1.25 g of sample material, either TMR or fecal, in two rumen-cannulated, lactating 
cows for 288 h (Huhtanen et al., 1994). The bags were then retrieved from the rumen, washed, 
dried, and analyzed for NDF (Van Soest et al., 1991). Urine samples (n = 1/cow) were collected 
on d 21 of each period and stored frozen at -20°C before being submitted to the Department of 
Veterinary Pathology of Iowa State University for determination of creatinine analysis. This 
metabolite was used as an internal marker to estimate urinary output. 
Milk data collection. Individual milk production was measured and recorded daily. Milk 
weights from the last 7 d of each period were used to evaluate milk production. Individual milk 
samples for milk composition analysis were obtained at 6 consecutive milking shifts on day 20 
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and 21 of each period. Samples were stored at 4°C with a preservative (Bronopol tablet; D & F 
Control System, San Ramon, CA) until analysis. Milk samples were analyzed for fat, true 
protein, lactose, MUN, and somatic cell count by an external laboratory (Dairy Lab Services, 
Dubuque, IA), using approved infrared analysis equipment and procedures (AOAC International, 
1995; method 972-16). Yields of milk components were estimated according to milk weight and 
time of collection. 
Plasma analyses. All blood samples were collected by venipuncture of the coccygeal 
vessels. Blood samples were obtained on d 21 of each period following the 0900 h milking. All 
samples were obtained using K2EDTA and K3EDTA (BD, Franklin Lakes, NJ) 10 mL and 3 mL 
vacuum tubes. Plasma was harvested following centrifugation at 1500 × g for 15 min at 4°C and 
were subsequently frozen at -20°C until analysis. Samples for complete blood count analysis 
were stored at 4°C for approximately 12 h before being submitted to the Department of 
Veterinary Pathology of Iowa State University for analysis. The same laboratory analyzed 
samples for hepatic enzymes, namely alanine aminotransferase, aspartate aminotransferase, and 
γ-glutamyltransferase. Haptoglobin (HP) and immunoglobin G (IgG) were determined using 
commercially available kits according to manufacturers’ instructions (haptoglobin, Immunology 
Consultants Laboratory, Inc., Lake Oswego, Oregon; IgG, Bethyl Laboratories, Inc., 
Montgomery, TX).  
Milk and urine AFM1 concentration analyses. For AF quantification, milk samples 
were analyzed by the University of Missouri Veterinary Diagnostic Laboratory, Columbia, MO. 
Milk samples were thawed and centrifuged at 1,875 × g and as much fat as possible was 
removed. The milk filtrates (10 mL) were then passed through AFLAPREP M immunoaffinity 
cleanup columns (R-Biopharm Rhone Ltd., Glasgow, Scotland). Columns were washed twice 
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with 10 mL of PBS, and AFM1 was then eluted from the columns with 1.5 mL of acetonitrile, 
followed by 1.5 mL of water. These elution fractions were placed in auto sample vials, and 
analyzed by high-performance liquid chromatography (HPLC) with fluorescence detection. The 
HPLC system consisted of a Hitachi Model L-7100 pump a Hitachi Model L-7485 fluorescence 
detector (365 nm excitation and 440 nm emission), a Hitachi Model L-7200 autosampler, a 
Hitachi D-7000 data acquisition interface, and Concert Chrom software on a microcomputer. The 
HPLC column was a 150 × 4.6 mm reversed-phase HyperClone 3-µm C18 BDS column 
(Phenomenex) with a C18 Security Guard precolumn (Phenomenex). The mobile phase was 
acetonitrile:methanol:water (15:15:70) and the flow-rate was 1 mL/min. The injection volume 
was 50 µL for all standards and samples. The detection limit was set at 40 ng/kg of AFM1. Urine 
samples were thawed and centrifuged at 1,875 × g. The urine filtrates (2 mL) were then 
processed and analyzed as previously described for milk samples.  
Animal measurements. Body weight and BCS (1 to 5 scale) were measured on d 20 and 
21 of each period after milking. The scoring method used was similar to that of Wildman et al. 
(1982) but reported to the quarter point. Two evaluators assessed BCS independently on 2 
consecutive days of each period and their scores were averaged 
Calculations and Statistical Analysis 
The first 14 d of each period were considered an adaptation/wash-out phase to avoid 
carry-over effects, whereas d 15 through 21 were utilized for data collection. All milk yield 
(MY) and DMI were condensed to means of the last 7 and 2 d of each period for analyses.  
Fat-corrected milk (FCM) was calculated as described by Tyrrell and Reid (1965) using 
the following equation: 3.5% FCM = (0.432 × milk yield, kg) + (16.23 × milk fat yield, kg). 
Feed efficiency (FE) was calculated as: FE = MY ÷ DMI. Dry matter digestibility was calculated 
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as: DIG % = [100 - (100 × iNDF TMR% ÷ iNDF Fecal %)]. Urine output (L/d) was calculated 
using estimations from Whittet (2004) assuming averages of 28 mg/kg of BW.  
Aflatoxin excretion and aflatoxin transfer were calculated based on milk production on 
the day of collection according to the following equations: 
AF excretion (µg/d) = concentration of AF in milk (µg/L) ×milk yield (kg/d) 
AF transfer % =
AF excretion (µg/d) 
AF intake (µg/d) ×100 
Urine AF excretion, urine transfer, and total fluid transfer (milk + urine) were calculated 
using the following equations:  
AF excretion (µg/d) = concentration of AF in urine (µg/L) ×urine output (L/d) 
AF transfer % =
AF excretion in urine (µg/d) 
AF intake (µg/d) ×100 
AF transfer in total fluid % =
AF excretion in urine (µg/d)+milk(µg/d) 
AF intake (µg/d) ×100 
Data were analyzed as replicated 3 × 3 Latin squares using the MIXED procedure of SAS 
(Version 9.4, SAS Institute Inc., Cary, NC). The fixed-effects of the model included square, 
period within square, and treatment. Random-effects included cow within square. The linear 
model for these data is written as follows: 
 
yijkm = µ + τm + β(τ)im + ρ(τ)jm + αk + εijkm 
 
Where yijkm is the observation ijkm; µ represents the overall mean; τm represents the fixed-effect 
of square m; β(τ)im represents the random-effect of cow i within square m; ρ(τ)jm represents the 
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fixed-effect of period j within square m; and αk represents the fixed-effect of treatment. The error 
term εijkm was assumed to be normally, independently, and identically distributed, with variance
2
eσ . Statistical significance for all treatment effects was declared at P ≤ 0.05. Trends are 
discussed at P ≤ 0.10. All mean results are presented as least square means ± the largest standard 
error of the mean unless stated otherwise. 
Results 
Diet Composition 
The ingredient composition and analyzed nutrient content of the basal TMR is presented 
in Table 2. Particle size distribution of TMR, according to the Penn State Particle Separator 
(Kononoff et al., 2003), was 18.6% > 19.0 mm upper sieve, 30.1% on the 19.0 – 9.0 mm sieve, 
35.6% on the 8.0 – 4.0 mm sieve, and 15.7% in the pan < 4.0 mm. 
Lactation Performance 
 Dry matter intake did not differ (P = 0.25) among dietary treatments averaging 24.0 ± 
0.92 kg/d (Table 3). Milk yield followed the same pattern as DMI and averaged 26.8 ± 1.34 kg/d 
across all treatments (P = 0.86). We also observed similar concentrations of fat (P = 0.81; 5.11 ± 
0.11%), protein (P = 0.42; 3.71 ± 0.11%), lactose (P = 0.18; 4.91 ± 0.03%), and MUN (P = 0.90) 
as well as somatic cell count (P = 0.49) across dietary treatments. Since DMI, milk yield and 
composition were similar, there were no treatment differences in FCM (P = 0.31) or feed 
efficiency (P = 0.36). Body weight (P = 0.41) and BCS (P = 0.92) were similar across 
treatments. 
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Digestibility, Urine and Fecal Output 
There were no differences (P = 0.48) for DM digestibility averaging 62.75 ± 2.74% 
across treatments. Likewise, urine (P = 0.21) and fecal output (P = 0.46) were similar across all 
dietary treatments averaging 57.76 ± 8.21 L/d and 9.28 ± 0.92 kg DM/d, respectively. 
Milk and Urine AFM1 Concentration 
No AFM1 was detected in milk or urine from cows consuming the CON diet indicating 
that the washout period was sufficient for effective clearance of AF. We observed a reduction in 
concentration of AFM1 in milk with the inclusion of ATX resulting in 1.14 ± 0.10 µg/L less 
compared to milk from cows consuming the AF diet. This is equivalent to a 27.40% reduction 
with inclusion of ATX at 0.10% of DMI (P ≤ 0.01; Table 4). Lower concentration is likely a 
result of reduced transfer rate to milk; this was reduced from 1.65 ± 0.13% with the AF diet to 
1.19 ± 0.13 % with the inclusion of AF+ATX. Because of reduced transfer rate, total excretion of 
AFM1 via milk was also reduced (P ≤ 0.01; Table 4). Cows that consumed AF excreted 41.33 ± 
3.19 µg/d via milk, whereas cows consuming the ATX excreted 29.69 µg/d (28.16% reduction; 
Table 4).  
Concentration of AFM1 in urine was 9.91 ± 1.23 µg/L for cows with the AF challenge 
whereas cows consuming AF+ATX had 5.87 ± 1.31 µg/L urine, resulting in a 40.76% reduction 
(P ≤ 0.04, Table 4). Transfer rate to urine was reduced from 24.34 ± 5.59% to 10.42 ± 5.96% 
from AF to AF+ATX, respectively. Cows that consumed AF excreted 608.44 ± 139.74 µg/d, 
which is 2.33-fold more AF compared to cows consuming ATX. Total fluid transfer of AFM1 
(milk + urine) decreased from 25.99 ± 5.62% in the AF group to 11.67 ± 6.00% for the AF+ATX 
group. 
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Plasma Chemistry Profile 
Complete blood cell counts were similar across all treatments (P ≥ 0.15; Table 5). 
Compared with CON, addition of AF and AF+ATX had no effect on blood concentration of 
alanine aminotransferase (61.1 ± 3.54 IU/L; P = 0.93, Table 5), aspartate aminotransferase (72.6 
± 5.46 IU/L; P = 0.26), and γ-glutamyltransferase (77.4 ± 6.98 IU/L; P = 0.34). There were no 
dietary treatment differences for haptoglobin (P = 0.57). Immunoglobin G concentration was not 
different between treatments (P = 0.75). 
Discussion 
The objective of this study was to evaluate the effect of dietary supplementation of 
silicoglycidol clay on the concentration of AFM1 in bovine milk and urine. Additionally, the 
response of biomarkers of liver function after an aflatoxin challenge in Holstein cows was 
evaluated. We postulated that dietary supplementation with silicoglycidol would reduce the 
transfer of AFM1 to milk and urine in addition to mitigating inflammatory response. 
No differences in productive outcomes such as DMI, MY and milk components were 
observed. Because of these similarities, secondary responses such as FE and FCM remained 
constant among dietary treatments. These observations are in accordance with other studies in 
which dairy cows received a similar AFB1 challenge with no effect on DMI and FE (Kutz et al., 
2009; Xiong et al., 2015; Maki et al., 2016a,b). Similar to our study, Ogunade et al. (2016) and 
Kutz et al. (2009) reported no differences in MY and composition. Although the common 
responses would suggest that dairy cows are relatively resilient to aflatoxin challenges, however, 
feeding such high levels of contaminated feed sometimes reduces performance. For example, 
(Sulzberger et al., 2017) reported differences in DMI upon receiving an AF challenge with no 
deleterious effects on milk production, hence differing in feed efficiency; whereas Queiroz et al. 
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(2012) reported that feeding an AF-containing diet reduced milk fat concentration and yield 
compared to the control diet (3.28 vs 3.36%; 0.67 vs 0.74 kg/d, respectively), thus reducing yield 
of FCM. Recently, Pate et al. (2018) reported that milk yield was affected linearly and 
quadratically when cows were fed 100 AF µg of AFB1/kg of dietary DM. It is noteworthy that 
for most studies, the experimental contamination levels with AF are similar (~100 µg AF B1/kg) 
and well above the FDA threshold for complete feed. Unfortunately, reasons for differences in 
responses among studies are not well understood. These differences may even arise from varying 
methodologies such as length of the challenge, timing of sampling and delivery route of the 
challenge. 
In the current study, cows that received the control diet had no detectable AFM1 
concentration in milk and urine indicating that the washout period was of sufficient length to 
clear AF from systemic circulation. Clay-based feed adsorbents have shown high efficacy at 
decreasing milk AFM1 concentration. For example, Maki et al. (2016a) utilized calcium 
montmorillionite clay, which reduced AFM1 concentrations in milk by 55% and 68% with levels 
of 121 µg/kg of AF. Kutz et al. (2009) reported that AFM1 concentration in milk was 
approximately 48% when cows consumed the same clay adsorbent as Maki et al., (2016a). As 
expected, the response was similar due to calcium montmorillonite clay being a highly specific 
and effective AFB1 sorbent; the 2:1 layered calcium montmorillonite structure can tightly bind to 
AFB1 in the interlayer surfaces, resulting in reduced unbound toxin in the gastrointestinal tract 
(Wang et al., 2017). Xiong et al. (2015) reported a 16.0% reduction of AFM1 concentration with 
the addition of an adsorbent at 0.25% of dietary DM when cows consumed contaminated diets 
with 20-40 µg AFB1/kg. The decreased reduction of AFM1 in milk when an adsorbent was fed 
compared to Maki et al. (2016a) and Kutz et al. (2009) could be due to the physical and chemical 
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difference of the structure. Xiong et al. (2015) researched sodium montmorillonite clay, and it is 
considered to be less selective due to swelling in water compared to calcium montmorillonite 
clay. Kissell et al. (2013) researched a variety of different adsorbents at 0.5% diet DM, and four 
of the products (HSCAS, sodium bentonite, experimental clay binder with unknown 
composition, and modified glucomannan) significantly reduced the AFM1 concentration, 
secretion, and transfer from feed to milk.  
Our results are in agreement with the aforementioned experiments, but two aspects are 
worth highlighting. Firstly, and to the best of our knowledge, this is the first documented report 
of using silicoglycidol clay for mitigation of AF in dairy cows. Secondly, our results indicate that 
this compound is highly effective at reducing AF absorption when fed at inclusion rates 5 to 10 
times lower compared to other clay-based adsorbents. Previous studies supplemented 100 – 500 
g/cow/day of clay adsorbent, whereas our supplementation rate of clay was at 28 g/cow/day 
(Kutz et al., 2004; Sulzberger et al., 2017). This is due to a modification where the 
aluminosilicate clay has undergone a specific patented treatment, which includes high 
temperature and ionic exchange to modify its structure and optimize mycotoxin binding. Also 
noteworthy to mention, the silicoglycidol clay is more effective with a broad spectrum of 
mycotoxins due to the ability to bind all five chemical groups: coumarinic, aminoalcholic, 
sesquitherpene, lactonic, and lactinic. It specifically works by forming hydrogen bonds between 
the oxygen atoms of silicate (SiO4) and the mycotoxin itself.  Previous studies reported transfer 
rates ranging from 0.25 to 4.8% in milk from dairy cows (Applebaum et al., 1982; Price et al., 
1985; Frobish et al., 1986; Veldman et al., 1992; Stroud, 2006). In our study, a lower transfer 
rate (1.65 vs 1.19%) was observed when feeding silicoglycidol at approximately 28 g/cow/d, 
compared to the diet with no adsorbent. Consequently, total daily AFM1 excretion was 28.2% 
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lower. This value is comparable to the dose response observations made by Sulzberger et al. 
(2017), in which there was a 25% reduction in AFM1 excretion with 0.5% of dietary clay, 
whereas 0.1 and 2% dietary inclusion, reduced excretion by 18 and 41%, respectively. These 
results differed from Pate et al. (2018), in which there were no observed difference in AFM1 
excretion when almuinosilicate clay was added to the diet; possible explanation stated by Pate et 
al. (2018) was due to the response of increased milk yield, FCM, and ECM when the sorbent was 
fed.  
Urine AF concentration was decreased from the AF to the AF+ATX diet in the current 
study from 9.91 µg/L to 5.87 µg/L with an inclusion rate of 0.10% of clay. Sulzberger et al. 
(2017) reported similar findings with urine AFM1 decreasing from 6.50 µg/kg to 4.38 µg/kg, and 
5.51 µg/kg with the 1% and 2% inclusion rate of clay, respectively. But, there was an increase of 
AFM1 in the urine with the 0.5% diet to 8.60 µg/kg. Shreeve et al. (1979) reported 0.75% 
concentration of AFM1 in urine compared to the AFB1 in the feed, suggesting that AF is excreted 
via the renal system. Numerous studies have documented the presence of AFM1 in human urine 
samples originating from consumption of contaminated food products. Zhu et al. (1987) 
determined that 1.23-2.18% of ingested AFB1 can be found as AFM1 in urine of animals and 
humans. Redzwan et al. (2012) reported that AFM1 was detected in 61.3% of 160 urine samples 
collected in Malaysia; this observation was associated with the consumption of dairy products. 
Their findings were comparable to a study conducted by Sulaiman et al. (2018) in which 444 
urine samples were collected and tested for AFM1, resulting in 44.8% positive for presence of 
the metabolite. To our knowledge, there are very few experiments reporting concentration of 
AFM1 in bovine urine, and even fewer studies reporting total urinary excretion of this metabolite. 
From our results, it is evident that most of the AFM1 is excreted via urine, accounting 608.4 µg/d 
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for of total excretion in bodily fluids (milk + urine). This result is similar to the report by 
Rodrigues et al. (2019). In both instances, urine output was not measured directly, rather it was 
estimated via two different methods. The paper by Rodrigues et al. (2019) relied on mineral 
analysis of TMR and equations to determine urine output whereas our methodology used 
creatinine as an internal marker. Furthermore, a common limitation between the work of 
Rodrigues et al. (2019) and our experiment is that urine was collected only once. Given the 
relative variability of grab-samples of TMR and the differences in analytical procedures for 
mineral determination in feedstuffs, we propose that future experiments considering urinary 
excretion of AF be based on total collection or repeated sampling for determination of internal 
markers for estimation of urine output. 
Mycotoxins are can have varying impacts on metabolism and immunity metrics. For 
example, Ogunade et al. (2016) reported that feeding the AF challenge reduced red blood cell 
counts and hemoglobin concentration with no differences in white blood cells, neutrophils, 
eosinophils, lymphocytes, basophils, and hematocrit. However, we were unable to detect 
significant differences in complete blood cell counts. In addition, plasma concentrations of IgG 
were also unaffected by treatment and observed to be within normal physiological range. 
Similarly, Xiong et al. (2015) reported no differences in IgG concentration when dairy cows 
consumed 20-40 µg/kg of DM with a 7-day AF challenge. Elevated concentrations of liver 
enzymes are indicators of acute or chronic liver disease; so we further investigated the 
hepatotoxic effects of AF by determining concentration of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) as biomarkers of liver 
function (Weemhoff et al., 2017; Pate et al., 2018). Stojević et al. (2005) researched the range of 
AST, ALT, and GGT activities in blood plasma of dairy cows and reported ranges of 19-84 U/L, 
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5-29 U/L, and 8-27 U/L for AST, ALT, and GGT, respectively. In the present study, mean 
concentration of AST, ALT, and GGT for all treatments were 61.11 IU/L, 72.63 IU/L, and 77.39 
IU/L. While concentration of AST was within normal limits, ALT and GGT concentrations were 
greater than normal physiological concentration across dietary treatments. We believe that the 
lack of response in liver enzymes could be due to prolonged exposure of AF. Development of 
toxin tolerance has been demonstrated in dairy cows by Dickson et al. (2019), even though AF 
and lipopolysaccharide (LPS) affect the immune system of the dairy cow in a disparate way. In 
that experiment, cows were intravenously infused with increasing doses of LPS and observed 
that cows reacted negatively at the initiation of the challenge period but became resilient over 
time up to doses that could have been lethal if administered as a bolus. Whereas Pate et al. 
(2018) reported a linear increase in plasma ALT with increasing clay concentrations in a short-
lived challenge, we evaluated liver function after 20 d of continuous exposure which may have 
allowed enough time to build resistance or become refractory to the toxin. In future studies liver 
function should be evaluated earlier in the challenge phase to characterize if an acute response 
exists followed by a refractory period. Haptoglobin is an acute-phase protein that increases with 
inflammatory stress and is an indicator of the innate immune status (Heegaard et al., 2000; 
Arthington et al., 2003; Bertoni et al., 2008; Queiroz et al., 2012); thus this protein would be 
expected to be elevated during an AF challenge. Contrary to this, we did not observe statistical 
differences in HP concentration even when feeding the AF challenge alone. However, there was 
a numerical decrease in HP concentration with the AF diet, which seemed to be reverted to 
normal levels with the AF+ATX diet. The HP concentration was 1.33 ± 0.36 µg/mL, 0.85 ± 0.36 
µg/mL, and 1.14 ± 0.38 µg/mL for the Control, AF, and AF+ATX diets, in that order. 
Interestingly, Ryan et al. (2017) observed a 2.27-fold down regulation in gene expression of HP 
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when comparing an AF challenge diet to their AF+clay treatment. Rather than finding an 
increase in acute-phase proteins during the AF challenge, it seems that AF may have had an 
immunosuppressive effect that was restored to normal levels upon consumption of silicoglycidol. 
Conclusion 
Aflatoxin contamination of feedstuffs is a concern in the dairy industry because of the 
inherent risk of increased AFM1 in dairy products intended for human consumption. The 
inclusion of silicoglycidol clay effectively reduced AFB1 concentration in milk by 27% and in 
urine by 41% with no effect on milk production or composition. The lack of response on most 
immune variables analyzed herein may indicate the ability of dairy cows to become refractory to 
toxins with prolonged exposure through unknown coping mechanisms. The numerical results 
with silicoglycidol clay suggest that it elicited a restorative effect on liver function that resulted 
in haptoglobin concentration similar to control cows, whereas AF challenge evidenced some 
degree of immune suppression. Whilst this observation is in agreement with gene expression 
work presented elsewhere, it remains to be demonstrated in concert in a single experiment.  
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Table 1. Adsorption of different mycotoxins by silicoglycidol clay1 at 2 different pH 
preparations  
 pH2 
 3.0 6.5 
Mycotoxin Adsorption % 
Aflatoxin 99.25 99.26 
Ochratoxin A 57.00 44.50 
Zearalenone 78.25 81.43 
T2 64.25 65.21 
Fumonisin 91.00 18.50 
Deoxynivalenol 91.00 18.50 
1Alquerfeed Antitox (Biovet S.A., Tarragona, Spain). 
2pH values are intended to represent physiological pH in different segments of the digestive 
tract. 
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Table 2. Ingredient and analyzed chemical composition of basal diet1 
Dietary ingredients % of dietary DM 
Corn silage  23.03 
Alfalfa baleage 16.37 
Alfalfa hay   4.02 
Ground corn 29.64 
Dry corn gluten feed   7.89 
Soybean meal  4.37 
Cottonseed, whole  3.87 
Expeller soybean meal  2.38 
Molasses  1.79 
Protein, vitamin and mineral 
pre-mix2   6.66 
  
Nutrient analysis, % DM   
CP 17.30 
NDF 26.10 
ADF 17.73 
Starch 27.20 
NFC3 45.67 
Ether extract   4.70 
Ash   7.25 
  
Particle size distribution  % retained in each sieve4 
  > 19.0 mm 18.61 
  19.0 – 9.0 mm 30.11 
  8.0 – 4.0 mm  35.58 
  < 4.0 mm  15.70 
1 Values represent an average of composite samples collected throughout 
the trial (n = 3). 
2 Contained soybean meal (Soyplus, West Central Cooperative, Ralston, 
IA), calcium carbonate, bloodmeal, sodium bicarbonate, rumen-inert fat 
(MagnaPalm, Energy Feeds International, Lago Vista, TX) , salt, daily 
micro premix, urea, magnesium oxide, antidoxidants/polyphenols 
(NutriTek Techology, Purina Animal Nutrition, Gray Summit, MO), 
methionine (Alimet, Novus, Saint Charles, MO), choice white grease, 
rumen protected methionine (Smartamine M, Kemin, Des Moines, IA), 
ionophore (Rumensin, Elanco, Fort Dodge, IA), biotin 2%, and 
performance minerals (Zinpro 120, Zinpro, Eden Prairie, MN).  
3 NFC = Non-fiber carbohydrates calculated by difference 100 – (%NDF + 
% CP + % EE + % Ash). 
4 Measured using the Penn State Particle Separator (Nasco, Fort Atkinson, 
WI). 
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Table 3. Effect of dietary addition of silicoglycidol clay1 on the performance of dairy cows consuming 
an aflatoxin (AF)-challenge diet 
 Dietary Treatment2 
SEM3 P-Value4 
 CON AF AF+ATX 
Dry matter intake, kg/day 24.61 23.66  23.79  0.92 0.25 
Milk yield, kg/day 26.90 26.65  26.88  1.34 0.86 
3.5% Fat corrected milk5, kg/day 33.75 32.87 32.60 1.55 0.31 
Fat, % 5.15 5.08  5.12  0.11 0.81 
Fat, kg 1.37 1.33  1.23  0.06 0.31 
Protein, % 3.81 3.66  3.65  0.11 0.42 
Protein, kg 1.02 0.96  0.94  0.06 0.22 
Lactose, % 4.88 4.92  4.92  0.03 0.18 
Lactose, kg 1.30 1.29  1.28  0.07 0.68 
MUN, mg/dL 13.45 13.36  13.53  0.44 0.90 
Somatic cell count 131.43 157.62  253.24  102.67 0.49 
      
Body weight, kg 673.60 678.51  673.78  19.23 0.41 
Body condition score6 3.65 3.67  3.65       0.09 0.92 
      
DM digestibility, % 60.06 64.71 63.48 2.74 0.48 
1Alquerfeed Antitox (Biovet S.A., Tarragona, Spain).  
2CON = Control; AF = Aflatoxin Challenge; AF+ATX = Aflatoxin Challenge + silicoglycidol clay 
3Greatest standard error of treatment mean is shown.  
4Main effect of treatment. 
53.5% Fat corrected milk = [milk fat (kg) × 16.216] + [milk yield (kg) × 0.4324]. 
6Body condition scores 1-5 scale (Wildman et al., 1982). 
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Table 4. Effect of dietary addition of silicoglycidol clay1 on aflatoxin M1 content in milk and urine 
from dairy cows consuming an aflatoxin-challenge diet 
 Dietary Treatment2 SEM3 P-value4  CON AF AF+ATX 
Intake of AF, µg/day - 2,500.00 2,500.00 . . 
Intake of clay, g/day -	 0.00 28.33 .	 .	
Milk data      
AFM1, µg/L -5 1.57 1.14 0.10 < 0.01 
Transfer, % - 1.65 1.19 0.13 < 0.01 
Excretion, µg/d - 41.33 29.69 3.19 < 0.01 
      
Urine data      
AFM1, µg/L - 9.91 5.87 1.32  < 0.01 
Transfer, % - 24.34 10.42 5.96 0.03 
Excretion, µg/d - 608.44 260.62 148.97 0.03 
      
Total excretion, µg/d - 649.77 291.75 149.89 0.02 
Total transfer, % - 25.99 11.67 6.00 0.02 
1Alquerfeed Antitox (Biovet S.A., Tarragona, Spain). 
2CON = basal TMR; AF = basal TMR + 100 µg of AFB1/kg DMI; AF+ATX = basal TMR + 
28.33 g of clay + 100 µg of AFB1/kg DMI. 
3Greatest standard error of treatment mean is shown. 
4Main effect of treatment. 
5Not detected.  
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Table 5. Effect of dietary addition of silicoglycidol clay1 on blood concentration of hepatic enzymes, 
white blood cell counts, and immune biomarkers of dairy cows consuming an aflatoxin (AF)-
challenge diet  
 Dietary Treatment2 SEM3 P-value4  CON AF AF+ATX 
Enzyme, IU/L      
ALT5 61.54 61.04 60.75 3.54 0.93 
AST6 65.83 74.92 77.13 5.46 0.26 
GGT7 79.25 76.63 76.29 6.98 0.34 
Biomarker, µg/mL      
Haptoglobin 1.33 0.85 1.1 0.38 0.57 
IgG 155.73 159.58 158.69 7.09 0.75 
Cell type, × 103/µL      
WBC8 9.23 9.59 9.18 1.21 0.76 
Neutrophils 3.75 3.79 3.78 0.54 0.99 
Lymphocytes 4.37 4.68 4.51 0.87 0.40 
Monocytes 0.52 0.53 0.46 0.06 0.59 
Eosinophils 0.45 0.40 0.32 0.05 0.15 
Basophils  0.10 0.11 0.11 0.02 0.76 
1Alquerfeed Antitox (Biovet S.A., Tarragona, Spain). 
2CON = basal TMR; AF = basal TMR + 100 µg of AFB1/kg DMI; AF+ATX = basal TMR + 28.33 g 
of clay + 100 µg of AFB1/kg DMI. 
3Greatest standard error of treatment mean is shown. 
4Main effect of treatment. 
5Alanine aminotransferase. 
6Aspartate aminotransferase. 
7Gamma glutamyltransferase. 
8White blood cells. 
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Figure 3. Effects of silicoglycidol clay on AFM1 
concentration in milk. 
Figure 4. Effects of silicoglycidol clay on AFM1 
concentration in urine. 
 
Figure 5. Effects of silicoglycidol clay on AFM1 
transfer in milk.  
 
Figure 6.	Effects of silicoglycidol clay on AFM1 
transfer in urine.   
 
Figure 7. Effects of silicoglycidol clay on AFM1 
excretion in milk  
 
Figure 8. Effects of silicoglycidol clay on AFM1 
excretion in urine. 
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CHAPTER 3: SUMMARY AND IMPLICATIONS 
 
 Mycotoxins, a secondary metabolite that is produced by are a detrimental food and feed 
safety concern to livestock and humans globally. Furthermore, this is a challenging issue due to 
increasing climate change and poor agriculture and harvesting techniques in many parts of the 
world. Nearly 25% of cereal grains are contaminated by mycotoxins, the US agriculture industry 
spends $31.1 million in mitigation strategies annually (Kurtzman et al., 1987; Robens and 
Cardwell, 2003, FAO, 2004). Out of 400 identified secondary metabolites, the five known for 
their toxic effects include ochratoxin A, zearalenone, trichothecenes type A: HT-2 and T-2 toxin; 
type B: deoxynivalenol), fumonisin, and aflatoxin (Jard et al., 2011; Marin et al., 2013; Tola and 
Kebede, 2016). Mycotoxicosis can produce a variety of effects from being a carcinogen to 
having immunosuppressive properties (Bennett and Klich, 2003; Jard et al., 2011). Focusing 
attention primarily on livestock species, potential negative effects include reduced feed intake, 
low feed efficiency, body weight loss or slow growth, lower milk production, and increased risk 
of health challenges. (Jard et al., 2011; Zain, 2011).  
 Due to the potential adverse effects, countries around the world have begun adopting 
regulations to aid in decreasing the potential exposure to mycotoxins. Within the category of 
metabolite, aflatoxin is the only mycotoxin that has an action level to ensure food safety because 
it can readily transfer into milk. The FDA has established an upper limit of 20 µg/kg for AFB1 in 
rations for lactating dairy cows and 0.5 µg/L for AFM1 in milk (FDA, 2000). Aflatoxin is a 
Group 1 carcinogen and has mutagenic and immunosuppressive properties (Peers et al., 1987; 
IARC, 2002). Even though the mechanism of AF has not been fully discovered, AFB1 transforms 
through epoxidation in liver by cytochrome P450 to AFB1 8,9-exo-endo epoxide, where it is 
metabolically activated. AFB1-8,9-exo-epoxide will bind to DNA at the N7 position of guanine, 
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where it will form AFB1-N7-guanine adducts. Through DNA modification, suppression and loss 
of the p53 gene will occur, hence development of hepatocellular carcinoma can begin (Abrar et 
al., 2013).   
 With the adverse effects of aflatoxin, nutrition and feed management strategies need to be 
utilized to decrease exposure. Feed additives, such as adsorbents, can be fed to inactivate or 
detoxify aflatoxin (Huwig et al., 2001; Whitlow, 2006). Adsorbents have been widely 
researched, with the range of including a variety of clay products from activated charocoal to 
hydrated sodium aluminosilicates. Phillips et al. (1999) extensively researched HSCAS, with 
finding this clay to be effective at sequestering aflatoxin in the gastrointestinal tract (Huwig et 
al., 2001). Even though adsorbents have a strong affinity for aflatoxin, they are variable for the 
other mycotoxins including ochratoxin A (OTA), zearalenone (ZEA), and deoxyivalenol (DON) 
(Huff et al., 1992; Patterson and Young, 1993; Abbès et al., 2007). Furthermore, silicoglycidol 
has been shown to bind more than one mycotoxin at low doses in swine but, to our knowledge, 
there is no report of its efficacy in ruminants (Binder et al., 2017). 
 The objectives of the present exeperiment were to determine the effects of silicoglyicidol 
clay on AFM1 concentrations in milk and urine, production performance, and inflammatory 
responses. Aflatoxin is considered a global food and feed safety concern for livestock and human 
consumption, and it is estimated that there is a transfer rate of 1.00 - 1.50% from feed to milk 
(Masoero et al., 2007). Therefore, we postulated that dietary supplementation with silicoglycidol 
clay would reduce AFM1 concentrations in milk and urine and mitigate an AF induced 
inflammatory response. Our results demonstrated that AF+ATX did not have any detrimental 
effects to production performance such MY, DMI, and milk components. The inclusion of the 
silicoglycidol clay effectively reduced milk and urine AFM1 concentration, transfer percentage, 
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and excretion. Although AF + ATX was effective at mitigating an AF challenge in dairy cattle, 
we did not observe any difference in blood biomarkers such as hepatic enzymes, antibodies, and 
acute phase proteins. Because of the lack of inflammatory responses, we speculated that dairy 
cows have the ability to overcome the toxin exposure through an unknown coping mechanism, 
which warrants further investigation.  
 In conclusion, our study demonstrated that supplying silicoglycidol clay to dairy cattle is 
an effective strategy to reduce concentration of AFM1 in milk and urine. However, blood 
inflammatory markers appeared to not be affected by dietary treatment of AF or AF + ATX. 
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